EHR

Cingulate Receives $3 Million Grant from Private Foundation to Accelerate Development of Anxiety Asset CTx-2103 (buspirone)Cingulate Receives $3 Million Grant from Private Foundation to Accelerate Development of Anxiety Asset CTx-2103 (buspirone)

Cingulate Receives $3 Million Grant from Private Foundation to Accelerate Development of Anxiety Asset CTx-2103 (buspirone)

CTx-2103 has the Potential to be the First, Once-Daily Formulation of Buspirone, one of the Most Widely Prescribed Agents in…

3 weeks ago
Context Therapeutics Doses First Patient in Phase 1 Clinical Trial of CT-95Context Therapeutics Doses First Patient in Phase 1 Clinical Trial of CT-95

Context Therapeutics Doses First Patient in Phase 1 Clinical Trial of CT-95

CT-95 is a mesothelin x CD3 T cell engaging bispecific antibody CT-95 is Context’s second T cell engaging bispecific antibody…

3 weeks ago
Aquestive Therapeutics to Participate in Piper Sandler Spring Biopharma SymposiumAquestive Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium

Aquestive Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium

WARREN, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing…

3 weeks ago
Assembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID CongressAssembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID Congress

Assembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID Congress

– Clinical and preclinical data supporting dosing profile and tolerability for ABI-5366, a novel long-acting helicase-primase inhibitor candidate, featured in…

3 weeks ago
ReMedi Health Solutions Earns High Performance Score in 2025 Best in KLAS Ratings for Clinical OptimizationReMedi Health Solutions Earns High Performance Score in 2025 Best in KLAS Ratings for Clinical Optimization

ReMedi Health Solutions Earns High Performance Score in 2025 Best in KLAS Ratings for Clinical Optimization

Exceptional provider ratings highlight ReMedi’s physician-led approach to improving clinical workflows and EHR efficiency. HOUSTON--(BUSINESS WIRE)--#EHR--ReMedi Health Solutions, a physician-led…

3 weeks ago
ReMedi Health Solutions Earns High Performance Score in 2025 Best in KLAS Ratings for Clinical OptimizationReMedi Health Solutions Earns High Performance Score in 2025 Best in KLAS Ratings for Clinical Optimization

ReMedi Health Solutions Earns High Performance Score in 2025 Best in KLAS Ratings for Clinical Optimization

Exceptional provider ratings highlight ReMedi’s physician-led approach to improving clinical workflows and EHR efficiency. HOUSTON--(BUSINESS WIRE)--#EHR--ReMedi Health Solutions, a physician-led…

3 weeks ago
Real Time Medical Systems to Present Strategies for Enhancing Value-Based Outcomes and Quality Improvement at 2025 AHCA/NCAL Quality SummitReal Time Medical Systems to Present Strategies for Enhancing Value-Based Outcomes and Quality Improvement at 2025 AHCA/NCAL Quality Summit

Real Time Medical Systems to Present Strategies for Enhancing Value-Based Outcomes and Quality Improvement at 2025 AHCA/NCAL Quality Summit

Clinical leaders to share actionable insights on leveraging live data analytics to drive value-based care success and enhance quality outcomes…

3 weeks ago
Therapy Brands Is Now Ensora HealthTherapy Brands Is Now Ensora Health

Therapy Brands Is Now Ensora Health

New name and brand identity reflect commitment to creating harmony between therapists, clients and broader healthcare community BOSTON, April 7,…

3 weeks ago
Aspargo Labs Expands Global Leadership TeamAspargo Labs Expands Global Leadership Team

Aspargo Labs Expands Global Leadership Team

NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a specialty pharmaceutical and…

3 weeks ago
Breakthrough Prize Foundation Announces Student Winner of 10th Annual Breakthrough Junior Challenge Science Video CompetitionBreakthrough Prize Foundation Announces Student Winner of 10th Annual Breakthrough Junior Challenge Science Video Competition

Breakthrough Prize Foundation Announces Student Winner of 10th Annual Breakthrough Junior Challenge Science Video Competition

Jasmine Eyal, Age 16, of Singapore, Receives Top Honors and $400,000 in Education Prizes for her Original Video Explaining Mechanogenetic…

3 weeks ago